GGrantIndex
Sort

326,823 grants matching clinical trial

Alabama-Clinical Trials Unit

$1,856,693
Michael S. Saag · University Of Alabama At Birmingham · UM1 · FY2012 · AI

BOSTON UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) PROGRAM UL1

$1,856,685
David M Center · Boston University Medical Campus · UL1 · FY2011 · RR

Core G: Biostatistics and Data Management

$1,856,628
Dana L Tudorascu · University Of Pittsburgh At Pittsburgh · U19 · FY2025 · AG

Assessment,Treatment, and Pharmacological Interventions in Alcoholic Patients

$1,856,542
David T George · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA

DNA Sequencing and FACS Core Facilities

$1,856,446
Paul Robbins · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease

$1,856,431
Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,856,065
Kenneth S Polonsky · Washington University · UL1 · FY2010 · RR

Treating mild cognitive impairment with transcranial direct current stimulation

$1,855,907
Benjamin Michael Hampstead · University Of Michigan At Ann Arbor · R01 · FY2020 · AG

CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICS

$1,855,895
University Of Arizona · U10 · FY2003 · HL

SCOR in Pathobiology of Lung Development

$1,855,659
Children'S Hospital Of Philadelphia · P50 · FY2001 · HL

Cold Chain-Independent, Needle-Free Mucosal Virosomal Vaccine to Prevent HIV-1 Acquisition at Mucosal Levels

$1,855,534
Ruth Margrit Ruprecht · University Of Louisiana At Lafayette · U19 · FY2020 · AI

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,855,531
Richard J. Barohn · University Of Kansas Medical Center · UL1 · FY2011 · RR

CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment

$1,855,454
Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2018 · AI

Innate immunity in clinical islet transplantation

$1,855,350
Olle Korsgren · Uppsala University · U01 · FY2006 · AI

Islet Transplant - Costimulatory Blockade with LEA29Y

$1,855,350
Andrew M Shapiro · University Of Alberta · U01 · FY2006 · AI

DNA virus as vectors for cardiovascular diseases

$1,854,749
James M Wilson · University Of Pennsylvania · P01 · FY2009 · HL

PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU

$1,854,633
Minneapolis Medical Research Fdn, Inc. · N01 · FY2000 · HC

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes - (ARMMS-T2D)

$1,854,546
John P. Kirwan · Cleveland Clinic Lerner Com-Cwru · U01 · FY2019 · DK

Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)

$1,854,519
Sanjiv S Gambhir · Stanford University · U54 · FY2015 · CA

AMPA Antagonism: A Novel Pharmacology for Launching Recovery from Opioid Addiction

$1,854,492
Robert Andrew Chambers · Indiana University Indianapolis · UG3 · FY2020 · DA

Northeast Node of the National Drug Abuse Clinical Trials Network

$1,854,476
Lisa A Marsch · Dartmouth College · UG1 · FY2023 · DA

A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis

$1,854,342
Nuria Tubau Juni · Biotherapeutics, Inc. · R44 · FY2025 · AR

Biomarkers of Catecholaminergic Neurodegeneration

$1,854,141
David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

Pre-clinical Translational Research Facility

$1,854,098
Mark Gilbert · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

Alcohol Pharmacokinetics and Pharmacodynamics in Humans

$1,854,006
Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA